Bank of America
BBP icon

Bank of America’s Virtus Biotech ETF BBP Stock Holding History

Bank of America’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-911
Closed -$46K – 8211
2021
Q3 		$46K Buy
+911
New +$47K ﹤0.01% 7080
2020
Q1 		– Sell
-85
Closed -$4K – 6839
2019
Q4 		$4K Buy
+85
New +$3.41K ﹤0.01% 6791
2019
Q3 		– Sell
-410
Closed -$17K – 7251
2019
Q2 		$17K Hold
410
– – ﹤0.01% 6604
2019
Q1 		$18K Buy
+410
New +$17.2K ﹤0.01% 6518
2017
Q3 		– Sell
-300
Closed -$12K – 7050
2017
Q2 		$12K Buy
+300
New +$11.2K ﹤0.01% 6372

Other funds holding BBP

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SMG
Smart Money Group Eastland, Texas $390M AUM 21.29% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
FAIM
Financial Advocates Investment Management Olympia, Washington $178M AUM 21.03% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America's BBP Position: Q4 2021 in Review

Bank of America sold out of Virtus Biotech ETF (BBP) in Q4 2021, closing a stake of 911 shares — an estimated $46K sold.

Bank of America first reported a position in BBP in Q2 2017 and held it in 5 quarters. The position peaked at $46K in Q3 2021. 12 funds tracked by Wall St. Rank hold BBP as of Q4 2021.

  • Bank of America reported no remaining Virtus Biotech ETF position as of Q4 2021 after selling out during the quarter.
  • Bank of America sold 911 Virtus Biotech ETF shares in Q4 2021, an estimated $46K.
  • Bank of America first reported a position in Virtus Biotech ETF in Q2 2017 and held it in 5 quarters.
  • Bank of America's Virtus Biotech ETF position peaked at $46K in Q3 2021.
  • 12 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q4 2021.

Based on Bank of America's 13F filing for Q4 2021, filed 8 Feb 2022.